Literature DB >> 26585255

WEB in Partially Thrombosed Intracranial Aneurysms: A Word of Caution.

G Anil1, A J P Goddard2, S M Ross3, K Deniz3, T Patankar2.   

Abstract

Despite the proved safety and efficacy of Woven EndoBridge (WEB) flow disruption in conventional intracranial saccular aneurysms, the literature on its use in partially thrombosed intracranial aneurysms is scarce. We report a series of 4 patients in whom partially thrombosed intracranial aneurysms were treated with the WEB. The 2 patients who received additional intraluminal treatment with conventional stents made a good clinical recovery. Meanwhile, those patients who were treated with the WEB alone had fatal rupture of the aneurysm at short- to medium-term follow-up. This small, select case series demonstrates that WEB placement with adjunctive stent placement may be an effective treatment in the management of partially thrombosed intracranial aneurysms, which merits further validation. However, exclusive intrasaccular flow disruption may have an adverse influence on the natural history of this disease.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26585255     DOI: 10.3174/ajnr.A4604

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

1.  Woven Endobridge (WEB) Device as a Retreatment Strategy After Unsuccessful Surgical Clipping.

Authors:  Thomas C Booth; Carmen Parra-Farinas; Ruth-Mary deSouza; Naga Kandasamy; Jo Bhattacharya; Prem Rangi; Jonathan Downer
Journal:  World Neurosurg       Date:  2020-03-13       Impact factor: 2.104

Review 2.  Comprehensive review of the recent advances in devices for endovascular treatment of complex brain aneurysms.

Authors:  Kavi Fatania; Dr Tufail Patankar
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039

3.  A Virtual Comparison of the eCLIPs Device and Conventional Flow-Diverters as Treatment for Cerebral Bifurcation Aneurysms.

Authors:  T W Peach; D Ricci; Y Ventikos
Journal:  Cardiovasc Eng Technol       Date:  2019-07-08       Impact factor: 2.495

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.